PowderMed Limited Company Profile

12:45 EDT 23rd March 2018 | BioPortfolio

PowderMed is an immunotherapeutic product company located in Oxford, UK. We have six lead programmes targeting influenza, chronic viral diseases and cancer. These products are all based on our proprietary DNA particle mediated epidermal delivery (PMED™) technology. This technology has been extensively validated as a delivery technology in human trials.PowderMed was founded in May 2004. Although a young company, PowderMed was launched with six mature clinical and preclinical programmes and a management team with many years experience in the pharmaceutical industry. Thus PowderMed combines the dynamism and entrepreneurship of a biotech startup with the professionalism and maturity of a long-established pharmaceutical company. In the first year of activity, PowderMed announced its first clinical results in the influenza programme and launched three further Phase I trials in its therapeutic vaccine programmes. PowderMed also has a subsidiary called PowderMed Vaccines Inc, a United States (U.S.) based commercial entity in Frederick, Maryland, alongside the important National Biodefense Analysis and Counterterrorist Countermeasures (NBACC) centre at Fort Detrick.


PO Box 1415
United Kingdom


Phone: 01865 501500
Fax: 01865 501501

News Articles [30 Associated News Articles listed on BioPortfolio]

Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussi...

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today that it has received a milestone payment from the Company’s Chinese partner for efti...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [82 Associated Companies listed on BioPortfolio]

PowderMed Limited

PowderMed is an immunotherapeutic product company located in Oxford, UK. We have six lead programmes targeting influenza, chronic viral diseases and cancer. These products are all based on our proprie...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...



VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "PowderMed Limited" on BioPortfolio

We have published hundreds of PowderMed Limited news stories on BioPortfolio along with dozens of PowderMed Limited Clinical Trials and PubMed Articles about PowderMed Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PowderMed Limited Companies in our database. You can also find out about relevant PowderMed Limited Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Corporate Database Quicklinks

Searches Linking to this Company Record